Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Landec Corporation (LNDC)

8.76   -0.32 (-3.52%) 11-14 16:00
Open: 9.01 Pre. Close: 9.08
High: 9.01 Low: 8.75
Volume: 52,474 Market Cap: 259(M)

Technical analysis

as of: 2022-11-28 4:41:17 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 11.14     One year: 12.26
Support: Support1: 8    Support2: 6.65
Resistance: Resistance1: 9.54    Resistance2: 10.5
Pivot: 9.08
Moving Average: MA(5): 8.92     MA(20): 9.03
MA(100): 9.66     MA(250): 10.12
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 16.4     %D(3): 22.5
RSI: RSI(14): 48
52-week: High: 12.03  Low: 7.65
Average Vol(K): 3-Month: 67 (K)  10-Days: 46 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ LNDC ] has closed above bottom band by 30.8%. Bollinger Bands are 11.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.19 - 9.26 9.26 - 9.32
Low: 8.69 - 8.77 8.77 - 8.82
Close: 8.73 - 8.86 8.86 - 8.94

Company Description

Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells differentiated health and wellness products for food and biomaterials markets in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. Landec Corporation was incorporated in 1986 and is headquartered in Santa Maria, California.

Headline News

Tue, 22 Nov 2022
Lifecore Biomedical, Inc. (LFCR) Stock Price Today, Quote & News - Seeking Alpha

Mon, 14 Nov 2022
Lifecore Biomedical Announces Completion of Corporate Name Change - (LNDC) - Benzinga

Thu, 10 Nov 2022
Lifecore Biomedical to Participate in the Stephens Annual Investment Conference on Thursday, November 17, 2022 -

Tue, 01 Nov 2022
Landec Expects to Change Corporate Name to Lifecore Biomedical and Ticker Symbol to “LFCR” on November 14 - Yahoo Finance

Thu, 06 Oct 2022
Landec (LNDC) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

Wed, 10 Aug 2022
Chaska's Lifecore Biomedical to become independent public company - Minneapolis / St. Paul Business Journal - The Business Journals

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. 30 (M)
Shares Float 18 (M)
% Held by Insiders 1.8 (%)
% Held by Institutions 85.3 (%)
Shares Short 357 (K)
Shares Short P.Month 546 (K)

Stock Financials

EPS -2.18
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 3.26
Profit Margin (%) -53.4
Operating Margin (%) -5.3
Return on Assets (ttm) -1.7
Return on Equity (ttm) -34.9
Qtrly Rev. Growth 4
Gross Profit (p.s.) 1.7
Sales Per Share 6.33
EBITDA (p.s.) 0.32
Qtrly Earnings Growth 0
Operating Cash Flow -27 (M)
Levered Free Cash Flow -25 (M)

Stock Valuations

PE Ratio -4.08
PEG Ratio -3.3
Price to Book value 2.7
Price to Sales 1.39
Price to Cash Flow -9.78

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.